JP2001522836A5 - - Google Patents

Download PDF

Info

Publication number
JP2001522836A5
JP2001522836A5 JP2000520420A JP2000520420A JP2001522836A5 JP 2001522836 A5 JP2001522836 A5 JP 2001522836A5 JP 2000520420 A JP2000520420 A JP 2000520420A JP 2000520420 A JP2000520420 A JP 2000520420A JP 2001522836 A5 JP2001522836 A5 JP 2001522836A5
Authority
JP
Japan
Prior art keywords
lower alkyl
phenyl
substituted
group
trihalomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000520420A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001522836A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/023225 external-priority patent/WO1999024406A1/en
Publication of JP2001522836A publication Critical patent/JP2001522836A/ja
Publication of JP2001522836A5 publication Critical patent/JP2001522836A5/ja
Pending legal-status Critical Current

Links

JP2000520420A 1997-11-07 1998-11-05 H3レセプターアンタゴニストとしてのフェニル−アルキル−イミダゾール Pending JP2001522836A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96626497A 1997-11-07 1997-11-07
US08/966,264 1997-11-07
PCT/US1998/023225 WO1999024406A1 (en) 1997-11-07 1998-11-05 Phenyl-alkyl-imidazoles as h3 receptor antagonists

Publications (2)

Publication Number Publication Date
JP2001522836A JP2001522836A (ja) 2001-11-20
JP2001522836A5 true JP2001522836A5 (enExample) 2006-01-05

Family

ID=25511129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000520420A Pending JP2001522836A (ja) 1997-11-07 1998-11-05 H3レセプターアンタゴニストとしてのフェニル−アルキル−イミダゾール

Country Status (12)

Country Link
EP (1) EP1028948B1 (enExample)
JP (1) JP2001522836A (enExample)
CN (1) CN1285823A (enExample)
AR (1) AR016416A1 (enExample)
AT (1) ATE231841T1 (enExample)
AU (1) AU1296899A (enExample)
CA (1) CA2309121A1 (enExample)
DE (1) DE69811110T2 (enExample)
ES (1) ES2188029T3 (enExample)
PE (1) PE130799A1 (enExample)
WO (1) WO1999024406A1 (enExample)
ZA (1) ZA9810184B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60017180T2 (de) * 1999-10-08 2005-12-08 Affinium Pharmaceuticals, Inc., Toronto Fab i inhibitoren
WO2004066960A2 (en) * 2003-01-28 2004-08-12 Schering Corporation Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA2551037A1 (en) 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. Novel piperidine derivative
US7423149B2 (en) * 2003-12-23 2008-09-09 Schering Corporation Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders
US7652041B2 (en) 2005-01-14 2010-01-26 Millennium Pharmaceuticals, Inc. Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
DK2861608T3 (da) 2012-06-19 2019-06-24 Debiopharm Int Sa Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid
BR112018016721A2 (pt) 2016-02-26 2018-12-26 Debiopharm Int Sa uso de di-hidrogeno fosfato de {6-[(e)-3-{metil[(3-metil-1-benfofuran-2-iol)metil]amino)-3-xopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)-il}metila e composição farmacêutica para tratamento de infecções bacterianas associadas ao pé diabético
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CA3139942A1 (en) 2019-06-14 2020-12-17 Justyna NOWAKOWSKA Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
AU693142B2 (en) * 1993-11-15 1998-06-25 Schering Corporation Phenyl-alkyl imidazoles as H3-receptor antagonists
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
ATE314071T1 (de) * 1996-08-16 2006-01-15 Schering Corp Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten

Similar Documents

Publication Publication Date Title
JP2001522836A5 (enExample)
JP2004516314A5 (enExample)
JP2005514366A5 (enExample)
JP2003519676A5 (enExample)
JP2007508359A5 (enExample)
JP2005518357A5 (enExample)
JP2006524225A5 (enExample)
JP2005501120A5 (enExample)
JP2010540593A5 (enExample)
JP2011507929A5 (enExample)
JP2001525411A5 (enExample)
JP2010513448A5 (enExample)
JP2006524222A5 (enExample)
JP2007508362A5 (enExample)
WO2002098857A8 (en) New indole derivatives with 5-ht6 receptor affinity
JP2006500394A5 (enExample)
JP2005505618A5 (enExample)
JP2002513793A5 (enExample)
JP2008502696A5 (enExample)
JP2010501478A5 (enExample)
JP2007510662A5 (enExample)
JP2002528493A5 (enExample)
JP2005514420A5 (enExample)
JP2006507355A5 (enExample)
JP2007519618A5 (enExample)